Upgrade to SI Premium - Free Trial

SciSparc (SPRC)

11.44 -0.10 (0.87%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (7/24/25 *Est.)

Latest Headlines

Form 6-K SciSparc Ltd. For: Jun 04 June 4, 2026 8:00 AM - SEC Filing NeuroThera Labs acquires 54% stake in CliniQuantum for CAD$9.5 million June 4, 2026 7:32 AM - StreetInsider SciSparc: Subsidiary NeuroThera Labs Completed Acquisition of CliniQuantum June 4, 2026 7:32 AM - Globe NewsWire Form 4 SciSparc Ltd. For: Jun 01 Filed by: Shrem Itschak June 3, 2026 8:00 AM - SEC Filing Form 6-K SciSparc Ltd. For: May 29 May 29, 2026 7:40 AM - SEC Filing NeuroThera Labs receives conditional approval for CliniQuantum acquisition May 28, 2026 8:40 AM - StreetInsider SciSparc: Subsidiary NeuroThera Labs Received Conditional Regulatory Approval for Acquisition of CliniQuantum May 28, 2026 8:40 AM - StreetInsider Form SCHEDULE 13G/A SciSparc Ltd. Filed by: L.I.A. Pure Capital Ltd May 15, 2026 4:26 PM - SEC Filing Form 6-K SciSparc Ltd. For: May 11 May 11, 2026 8:00 AM - SEC Filing Form 20-F SciSparc Ltd. For: Dec 31 April 29, 2026 4:22 PM - SEC Filing Form 3 SciSparc Ltd. For: Mar 18 Filed by: DAYAN ALON March 23, 2026 4:01 PM - SEC Filing Form 3 SciSparc Ltd. For: Mar 18 Filed by: Adler Oz March 18, 2026 4:02 PM - SEC Filing Form 3 SciSparc Ltd. For: Mar 18 Filed by: Revach Moshe March 18, 2026 4:02 PM - SEC Filing Form 3 SciSparc Ltd. For: Mar 18 Filed by: Shay Amnon Ben March 18, 2026 4:01 PM - SEC Filing Form 3 SciSparc Ltd. For: Mar 18 Filed by: Shrem Itschak March 18, 2026 4:01 PM - SEC Filing Form 3 SciSparc Ltd. For: Mar 18 Filed by: Sidi Liat March 18, 2026 4:01 PM - SEC Filing Form 3 SciSparc Ltd. For: Mar 18 Filed by: Weiss Amitay March 18, 2026 4:01 PM - SEC Filing Form 3 SciSparc Ltd. For: Mar 18 Filed by: Vider Lior March 18, 2026 4:01 PM - SEC Filing Form 3 SciSparc Ltd. For: Mar 18 Filed by: Zuloff-Shani Adi March 18, 2026 4:01 PM - SEC Filing Form SCHEDULE 13G SciSparc Ltd. Filed by: Fatal Ronen March 16, 2026 4:33 PM - SEC Filing Form SCHEDULE 13G SciSparc Ltd. Filed by: Zamir Eli March 16, 2026 4:22 PM - SEC Filing Form 6-K SciSparc Ltd. For: Mar 16 March 16, 2026 4:01 PM - SEC Filing SciSparc subsidiary files patent application for depression treatment March 16, 2026 8:21 AM - StreetInsider SciSparc: NeuroThera Labs- Clearmind Medicine Collaboration Leads to Patent Application for Depression Therapy March 16, 2026 8:20 AM - StreetInsider Clearmind Medicine files Hong Kong patent for depression therapy combo March 13, 2026 7:46 AM - StreetInsider Clearmind Medicine Announces Hong Kong Patent Filing for Depression Therapy March 13, 2026 7:45 AM - Globe NewsWire Form 6-K SciSparc Ltd. For: Mar 12 March 12, 2026 4:42 PM - SEC Filing SciSparc subsidiary publishes patent for obesity treatment combination March 12, 2026 7:55 AM - StreetInsider SciSparc: NeuroThera Labs Announces Publication of International Patent in Collaboration with Clearmind Medicine for Novel Therapy Targeting Weight Loss and Fatty Liver Disease March 12, 2026 7:55 AM - StreetInsider NeuroThera to acquire majority stake in quantum clinical trials firm March 10, 2026 9:28 AM - StreetInsider SciSparc: Subsidiary NeuroThera Labs (75%) Signs Definitive Agreement to Acquire Majority Stake in CliniQuantum, Innovator in Quantum-based Clinical trails March 10, 2026 9:28 AM - StreetInsider Clearmind Medicine receives international patent for weight loss therapy March 10, 2026 8:59 AM - StreetInsider Clearmind Medicine Announces Publication of International Patent for Novel Therapy Targeting Weight Loss and Fatty Liver Disease March 10, 2026 8:59 AM - StreetInsider Form SCHEDULE 13G/A SciSparc Ltd. Filed by: Daniel Nissim March 9, 2026 4:30 PM - SEC Filing Full Article List